Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

NCT00981799 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Slow accrual rate

Conditions

Relapsed T-Cell Acute Lymphoblastic Leukemia
Relapsed T-Cell Lymphoblastic Lymphoma

Interventions

DRUG: Nelarabine
DRUG: Etoposide
DRUG: Cyclophosphamide
DRUG: Methotrexate
DRUG: Filgrastim

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium

Collaborators

[object Object]
[object Object]